Theriva Biologics, Inc.
TOVX •
Buy Open
Signal type
Buy
Status
Open
Open Price
$0.31
Stop Loss
Performance
-22.26%
Days Open
7
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 8, 2026
Open Price $0.31
Stop Loss -
Timespan Day
Company Profile
Name Theriva Biologics, Inc.
Ticker TOVX
Market Cap $3.93M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $0.24
List Date Apr 5, 1993
Description
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
Website Open Company Website